Primavera: A new therapeutical approach to vulvo-vaginal atrophy
Autor: | Torello Lotti, Veronica Di Nardo, Georgi Tchernev, G Vitiello, P Amori, Uwe Wollina, Katlein França, Jana Hercogová, Farah Daaboul |
---|---|
Rok vydání: | 2018 |
Předmět: |
Vaginal Diseases
Physiology Dermatology Vulvovaginal atrophy Antioxidants Vulva 030207 dermatology & venereal diseases 03 medical and health sciences 0302 clinical medicine Quality of life Humans Rejuvenation Medicine Pregnancy business.industry Cancer Recovery of Function General Medicine medicine.disease Menopause Sexual desire Treatment Outcome Vagina Female Vulvar Diseases Vaginal atrophy Atrophy business Oligopeptides 030215 immunology Hormone |
Zdroj: | Dermatologic Therapy. 31:e12678 |
ISSN: | 1396-0296 |
DOI: | 10.1111/dth.12678 |
Popis: | Vulvovaginal atrophy is a condition that affects women, although it is mainly associated with the onset of menopause mainly due to hormonal changes vulvovaginal laxity and mucosal atrophy can also affect women at different life stages such as after pregnancy or for cancer patients who have undergone chemo or endocrine therapy. This condition negatively influence quality of life, sexual desire, and self-confidence. Many therapies have been considered mainly with inconclusive or transient results in terms of benefit factor. Recently, a new non-invasive product, containing hyaluronic acid, oligopeptides, and antioxidants was introduced to the market. Its name is "Primavera," by Renaissance, Italy. The aim of this product is to allow a vulvo-vaginal biostimulation and considered simple, safe, and satisfactory. |
Databáze: | OpenAIRE |
Externí odkaz: |